8 completed, 4 unknown, 2 terminated. 14 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 8, Unknown 4, Terminated 2 |
| Phase 2 | 3 | Unknown 3 |
Follow Statin: new trials by email Literature Review of Statin trials Research Report on Statin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage Statin - Intracerebral Hemorrhage, Statins | Phase 2 / Phase 3 | Unknown | Capital Medical University | 98 | 2021-08-06 | 2024-01-23 |
| Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 intermediate dose Enoxaparin/ unfractionated heparin, standard prophylactic dose Enoxaparin/ unfractionated heparin, Atorvastatin 20mg - Covid19 | Phase 3 | Completed | Rajaie Cardiovascular Medical and Research Center | 600 | 2020-07-30 | 2021-08-17 |
| The Benefit of Add On DLBS1033 for Ischemic Stroke Patient DLBS1033, Aspirin, Statin - Ischemic Stroke | Phase 2 / Phase 3 | Unknown | Duta Wacana Christian University | 180 | 2020-04-01 | 2020-06-11 |
| Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin Aspirin, Atorvastatin, Placebo Aspirin - Acute Chest Syndrome | Phase 3 | Terminated | Dr. med. Mahir Karakas | 68 | 2020-02-21 | 2022-05-24 |
| Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia Gefarnate, Statin - Coronary Artery Disease | Phase 2 / Phase 3 | Unknown | First Affiliated Hospital of Harbin Medical University | 70 | 2019-09-01 | 2020-07-30 |
| Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone Sulodexide, Statin, Antiplatelet Agents - Peripheral Arterial Obstructive Disease | Phase 3 | Unknown | Alfa Wassermann Tunisia | 156 | 2019-01-31 | 2019-12-02 |
| Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes Statin, Atorvastatin, Placebo - Carotid Artery Stenosis, Strokes | Phase 3 | Terminated | Columbia University | 31 | 2017-06-01 | 2026-05-07 |
| Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy Vitamin D, Simvastatin, Placebo - Dyslipidemias | Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 33 | 2013-12-01 | 2017-03-31 |
| Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1) Placebo (for alirocumab), Alirocumab, Statin - Hypercholesterolemia | Phase 3 | Completed | Regeneron Pharmaceuticals | 803 | 2013-09-01 | 2017-03-21 |
| Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial Statin, ACE inhibitor, Placebo - Type 1 Diabetes | Phase 3 | Completed | University of Cambridge | 443 | 2009-01-01 | 2018-06-28 |
| Carotid Intima-media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo) Statin - Ischemic Stroke | Phase 3 | Completed | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 854 | 2004-03-01 | 2016-04-25 |
| hsCRP in Japan Statin Treatment Against Recurrent Stroke (J-STARS hsCRP) Statin - Ischemic Stroke | Phase 3 | Completed | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 1095 | 2004-03-01 | 2016-04-25 |
| Intima Media Thickness Regression in Dyslipidemic Teenagers Atorvastatin, sugar pill - Obesity, Dyslipidemia | Phase 3 | Completed | Université de Montréal | 16 | 2004-01-01 | 2013-01-15 |
| A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173) Ezetimibe, Placebo, Simivastatin - Primary Hypercholesterolemia | Phase 3 | Completed | Organon and Co | 769 | 2001-01-31 | 2024-05-10 |
Stroke (4) · Hypercholesterolemia (3) · Ischemic Stroke (3) · Brain Ischemia (2) · Dyslipidemias (2) · Hyperlipidemias (2) · Recurrence (2) · Acute Chest Syndrome (1) · COVID-19 (1) · Carotid Stenosis (1) · Cerebral Hemorrhage (1) · Coronary Artery Disease (1) · Diabetes Mellitus, Type 1 (1) · Motor Activity (1) · Obesity (1)
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (2) · Alfa Wassermann Tunisia (1) · Capital Medical University (1) · Columbia University (1) · Dr. med. Mahir Karakas (1) · Duta Wacana Christian University (1) · First Affiliated Hospital of Harbin Medical University (1) · Organon and Co (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Rajaie Cardiovascular Medical and Research Center (1) · Regeneron Pharmaceuticals (1) · University of Cambridge (1) · Université de Montréal (1)
Canada (3) · China (2) · Japan (2) · United States (2) · Australia (1) · Bulgaria (1) · Germany (1) · Hungary (1) · India (1) · Indonesia (1) · Iran (1) · Israel (1) · Norway (1) · Slovakia (1) · Tunisia (1)
Masayasu Matsumoto, MD, PhD (2) · Anil Bhansali, DM (1) · Behnood Bikdeli, MD, MS (1) · David B Dunger, Professor (1) · Edward S Connolly, MD, FACS (1) · Eric Heyer, MD, Ph.D. (1) · Imed Frikha, MD (1) · Laurent Legault, MD (1) · Mahir Karakas, MD (1) · Parham Sadeghipour, MD (1) · Rizaldy Pinzon, MD, MSc, PhD (1)
PMID 12423708, PMID 15811480, PMID 22416821, PMID 25392936, PMID 27639753, PMID 29091568, PMID 29191850, PMID 31035902, PMID 31166599, PMID 32108022, PMID 32928709, PMID 32992075, PMID 33100044, PMID 33734299, PMID 34996756, PMID 35165110, PMID 35244208, PMID 36944357, PMID 38124088, PMID 38908848, PMID 39673820, PMID 42056188, PMID 42718842